David McClung, Chief Financial Officer at BioCardia, Inc. (BCDA), bought 2,850 shares at $2.45 ($7K) on 2018-09-25, disclosed to the SEC on 2018-09-25.
Open-market purchase of $7k BCDA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| BCDA | BUY | 2022-10-11 | $4K | — | Filing → |
| BCDA | BUY | 2018-11-07 | $4K | — | Filing → |
| BCDA | BUY | 2018-10-16 | $1K | — | Filing → |